IgG subclasses in epileptic patients treated with phenytoin
- 1 March 1989
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 236 (3) , 149-152
- https://doi.org/10.1007/bf00314330
Abstract
IgG1, IgG2, IgG3 and IgG4 serum concentrations were determined in 49 phenytoin-treated epileptic patients and in 19 untreated epileptic controls, using subclass-specific monoclonal antibodies in an ELISA technique. The IgG3 and IgG4 concentrations were significantly reduced in patients with IgA deficiency (PPP<0.05). IgG1 and IgG2 concentrations did not differ in phenytoin-treated and untreated epileptic patients. IgG1, IgG2, IgG3 and IgG4 did not change after withdrawal of phenytoin. IgG subclass concentrations were not significantly correlated with frequency of respiratory tract infections.This publication has 28 references indexed in Scilit:
- Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patientsActa Neurologica Scandinavica, 2009
- Impaired Lung Function in Patients with IgA Deficiency and Low Levels of IgG2 or IgG3New England Journal of Medicine, 1985
- Transient Antibody Deficiency and Abnormal T Suppressor Cells Induced by PhenytoinNew England Journal of Medicine, 1982
- Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsyInternational Journal of Immunopharmacology, 1982
- HLA antigens in epileptic patients with drug-induced immunodeficiencyInternational Journal of Immunopharmacology, 1982
- Respiratory Disease in Patients with Epilepsy on Single-Drug Therapy with Carbamazepine or PhenobarbitalEuropean Neurology, 1982
- EFFECT OF PHENYTOIN ON IMMUNOGLOBULIN CONCENTRATIONS IN NASAL SECRETIONSActa Pathologica Microbiologica Scandinavica Section C Immunology, 1981
- Immunoglobulins in ataxia-telangiectasia: Evidence for IgG4 and IgA2 subclass deficienciesClinical Immunology and Immunopathology, 1981
- IgG Subclasses in Selective IgA DeficiencyNew England Journal of Medicine, 1981
- IgA DEFICIENCY, EPILEPSY, AND HYDANTOIN MEDICATIONThe Lancet, 1976